Overview

Hepatopulmonary (hep-uh-toe-POOL-moe-nar-e) syndrome is caused by blood vessels in the lungs expanding, also called dilating, and increasing in number. This condition affects the lungs of people who have advanced liver disease.

These changes in the lungs make it hard for red blood cells to take in oxygen. Then the lungs can't send enough oxygen to the body. This leads to low oxygen levels in the blood, also called hypoxemia.

How liver disease is linked to the lung condition isn't yet known. A liver transplant is the only cure for hepatopulmonary syndrome.

Symptoms

Often, there are no symptoms of hepatopulmonary syndrome. If there are symptoms, they can include:

  • Shortness of breath that's worse when sitting or standing and gets better when lying down.
  • Clubbing of the fingers, in which the fingertips spread out and become rounder than usual.
  • Broken blood vessels under the skin, called spider angioma.
  • Bluish tinge of the lips and skin in white people. In Black and brown people, the lips or tongue might look light gray. This change in color is called cyanosis.

Causes

Hepatopulmonary syndrome is caused when blood vessels in and around the lungs widen, also called dilate. This affects the amount of oxygen that moves from the lungs into the bloodstream.

What causes this is not clear. And it's not known why some people with liver disease develop hepatopulmonary syndrome while others do not.

Jan. 19, 2024

Living with hepatopulmonary syndrome?

Connect with others like you for support and answers to your questions in the Transplants support group on Mayo Clinic Connect, a patient community.

Transplants Discussions

lmctif
Liver transplant - Let's support each other

1617 Replies Wed, Nov 13, 2024

jolinda
Transplant anti-rejection medications. What's your advice?

362 Replies Sun, Nov 10, 2024

See more discussions
  1. Ferri FF. Hepatopulmonary syndrome. In: Ferri's Clinical Advisor 2024. Elsevier; 2024. https://www.clinicalkey.com. Accessed Oct. 23, 2024.
  2. Lange PA, et al. Hepatopulmonary syndrome in adults: Prevalence, causes, clinical manifestations, and diagnosis. https//www.uptodate.com/contents/search. Accessed Oct. 13, 2023.
  3. Hepatopulmonary syndrome. National Organization for Rare Disorders. https://rarediseases.org/rare-diseases/hepatopulmonary-syndrome/. Accessed Oct. 13, 2023
  4. Raevens S, et al. Hepatopulmonary syndrome. JHEP Reports. 2022; doi:10.1016/j.jhepr.2022.100527.
  5. Ami TR. Allscripts EPSi. Mayo Clinic. Dec. 6, 2023.
  6. Baquir M (expert opinion). Mayo Clinic. Nov. 6, 2023.

Related

News from Mayo Clinic

Products & Services